119 related articles for article (PubMed ID: 2655625)
1. The effect of placebo in the alcohol withdrawal state.
Lichtigfeld FJ; Gillman MA
Alcohol Alcohol; 1989; 24(2):109-12. PubMed ID: 2655625
[TBL] [Abstract][Full Text] [Related]
2. Alcohol withdrawal syndrome: clinical and hormonal responses to alpha 2-adrenergic agonist treatment.
Cushman P; Sowers JR
Alcohol Clin Exp Res; 1989 Jun; 13(3):361-4. PubMed ID: 2568765
[TBL] [Abstract][Full Text] [Related]
3. [Psychosocial treatment plus drug prophylaxis. Fewer recurrences after alcohol withdrawal].
Smolka MN; Kiefer F; Mann K
MMW Fortschr Med; 2003 Sep; 145(35-36):45. PubMed ID: 14584210
[No Abstract] [Full Text] [Related]
4. Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.
Koethe D; Juelicher A; Nolden BM; Braunwarth WD; Klosterkötter J; Niklewski G; Wodarz N; Klatt J; Burtscheidt W; Gaebel W; Markus Leweke F
Alcohol Clin Exp Res; 2007 Jul; 31(7):1188-94. PubMed ID: 17511748
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of acamprosate for the treatment of alcohol dependence long after recovery from withdrawal syndrome: a randomized, double-blind, placebo-controlled study conducted in Japan (Sunrise Study).
Higuchi S;
J Clin Psychiatry; 2015 Feb; 76(2):181-8. PubMed ID: 25742205
[TBL] [Abstract][Full Text] [Related]
6. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
[TBL] [Abstract][Full Text] [Related]
7. Alcohol withdrawal syndromes: clinical management with lofexidine.
Cushman P; Forbes R; Lerner W; Stewart M
Alcohol Clin Exp Res; 1985; 9(2):103-8. PubMed ID: 3890587
[TBL] [Abstract][Full Text] [Related]
8. The administration of transcranial electric treatment for affective disturbances therapy in alcoholic patients.
Krupitsky EM; Burakov AM; Karandashova GF; Katsnelson JaS ; Lebedev VP; Grinenko AJa ; Borodkin JuS
Drug Alcohol Depend; 1991 Jan; 27(1):1-6. PubMed ID: 2029855
[TBL] [Abstract][Full Text] [Related]
9. Halazepam in the management of acute alcohol withdrawal syndrome.
Mendels J; Wasserman TW; Michals TJ; Fine EW
J Clin Psychiatry; 1985 May; 46(5):172-4. PubMed ID: 2859274
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
[TBL] [Abstract][Full Text] [Related]
11. Flumazenil in alcohol withdrawal: a double-blind placebo-controlled study.
Potokar J; Coupland N; Glue P; Groves S; Malizia A; Bailey J; Wilson S; Nutt D
Alcohol Alcohol; 1997; 32(5):605-11. PubMed ID: 9373703
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of and physiological responses to nitrous oxide gas treatment during alcohol withdrawal: a double-blind, placebo-controlled trial.
Alho H; Methuen T; Paloheimo M; Strid N; Seppä K; Tiainen J; Salaspuro M; Roine R
Alcohol Clin Exp Res; 2002 Dec; 26(12):1816-22. PubMed ID: 12500105
[TBL] [Abstract][Full Text] [Related]
13. [Cue-induced alcohol craving. Neurobiological correlates and clinical relevance].
Wrase J; Grüsser SM; Heinz A
Nervenarzt; 2006 Sep; 77(9):1051-2, 1055-8, 1060-3. PubMed ID: 16534643
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled trial of magnesium sulfate in the ethanol withdrawal syndrome.
Wilson A; Vulcano B
Alcohol Clin Exp Res; 1984; 8(6):542-5. PubMed ID: 6393805
[TBL] [Abstract][Full Text] [Related]
15. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.
Gann H; Feige B; Cloot O; Van Wasen H; Zinzgraf D; Hohagen F; Riemann D
Pharmacopsychiatry; 2004 Sep; 37(5):228-35. PubMed ID: 15359376
[TBL] [Abstract][Full Text] [Related]
16. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
[TBL] [Abstract][Full Text] [Related]
17. Alcohol withdrawal and mood.
Bokström K; Balldin J; Långström G
Acta Psychiatr Scand; 1989 Nov; 80(5):505-13. PubMed ID: 2596351
[TBL] [Abstract][Full Text] [Related]
18. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal.
Malcolm R; Ballenger JC; Sturgis ET; Anton R
Am J Psychiatry; 1989 May; 146(5):617-21. PubMed ID: 2653057
[TBL] [Abstract][Full Text] [Related]
19. Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.
Lyon JE; Khan RA; Gessert CE; Larson PM; Renier CM
J Hosp Med; 2011 Oct; 6(8):469-74. PubMed ID: 21990176
[TBL] [Abstract][Full Text] [Related]
20. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
